David Scott Miller, MD, FACOG, FACS

@dsmgyo.bsky.social

11 months ago

Comparing #durvalumab, #olaparib, and #cediranib, or chemotherapy in platinum-resistant #ovariancancer: the @nrgonc.bsky.social GY023 trial

url:aacrjournals.org/clincancerres/article-ab...

#gyncsm